Skip to main content Skip to section navigation Skip to footer
Back to checkpointtx.com

Checkpoint Therapeutics, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 02, 2023

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Feb 21, 2023

Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jan 17, 2023

Checkpoint Therapeutics to Participate in the B. Riley Securities’ 3rd Annual Oncology Conference

Jan 04, 2023

Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dec 15, 2022

Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 05, 2022

Checkpoint Therapeutics Announces Reverse Stock Split

Nov 08, 2022

Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

Sep 22, 2022

Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

Sep 08, 2022

Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

Aug 12, 2022

Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Checkpoint Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.